Inhibition of neuroeffector transmission in human vas deferens by sildenafil

Publisher Website
Google Scholar
Abstract
Sildenafil (0.1–30 μM), a cyclic GMP phosphodiesterase 5 (PDE 5) inhibitor, induced inhibition of electrically evoked contractions of ring segments of human vas deferens from 34 vasectomies. Zaprinast (0.1–100 μM), another PDE 5 inhibitor, and the nitric oxide (NO) donor sodium nitroprusside (SNP) (0.1–100 μM) had no effect on neurogenic contractions. The inhibition induced by sildenafil was not modified by the inhibitor of guanylate cyclase 1H‐[1,2,4]oxadiazolo[4,3‐a]quinoxaline‐1‐one (ODQ) (1–30 μM) but it was abolished by the K+ channel blockers tetraethylammonium (TEA, 1 mM), iberiotoxin (0.1 μM) and charybdotoxin (0.1 μM). Sildenafil, zaprinast and SNP did not affect the contractions induced by noradrenaline. SNP (10 μM) caused elevation of cyclic GMP levels that was potentiated by sildenafil (10 μM) and zaprinast (100 μM). ODQ (10 μM) inhibited the increase in cyclic GMP. Sildenafil inhibits adrenergic neurotransmission in human vas deferens. The inhibition is not related to accumulation of cyclic GMP but is probably due to activation of prejunctional large‐conductance Ca2+‐activated K+ channels.British Journal of Pharmacology (2000) 131, 871–874; doi:10.1038/sj.bjp.0703657